These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23581664)

  • 1. Pharmaceutical knowledge governance: a human rights perspective.
    Lemmens T
    J Law Med Ethics; 2013; 41(1):163-84. PubMed ID: 23581664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].
    Allard Soto R
    Salud Colect; 2015 Mar; 11(1):9-21. PubMed ID: 25853827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global constitutionalism, applied to global health governance: uncovering legitimacy deficits and suggesting remedies.
    Ooms G; Hammonds R
    Global Health; 2016 Dec; 12(1):84. PubMed ID: 27914471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interdependence, Human Rights and Global Health Law.
    Viens AM
    Health Care Anal; 2015 Dec; 23(4):401-17. PubMed ID: 26240020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction: pharmaceutical innovation: law & the public's health.
    Outterson K
    J Law Med Ethics; 2009; 37(2):173-5. PubMed ID: 19493064
    [No Abstract]   [Full Text] [Related]  

  • 6. Human rights responsibilities of pharmaceutical companies in relation to access to medicines.
    Lee JY; Hunt P
    J Law Med Ethics; 2012; 40(2):220-33. PubMed ID: 22789042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Security, development and human rights: normative, legal and policy challenges for the international drug control system.
    Barrett D
    Int J Drug Policy; 2010 Mar; 21(2):140-4. PubMed ID: 20116987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from the experience of U.N. Convention on the Rights of Persons With Disabilities: addressing the democratic deficit in global health governance.
    Lord JE; Suozzi D; Taylor AL
    J Law Med Ethics; 2010; 38(3):564-79. PubMed ID: 20880241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respecting the right to access to medicines: Implications of the UN Guiding Principles on Business and Human Rights for the pharmaceutical industry.
    Moon S
    Health Hum Rights; 2013 Jun; 15(1):E32-43. PubMed ID: 25006088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global constitutionalism, responsibility to protect, and extra-territorial obligations to realize the right to health: time to overcome the double standard (once again).
    Ooms G; Hammonds R
    Int J Equity Health; 2014 Oct; 13():68. PubMed ID: 25928731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed consent: Enforcing pharmaceutical companies' obligations abroad.
    Lee SB
    Health Hum Rights; 2010 Jun; 12(1):15-28. PubMed ID: 20930251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Damned if you do, damned if you don't? The Lundbeck case of pentobarbital, the guiding principles on business and human rights, and competing human rights responsibilities.
    Buhmann K
    J Law Med Ethics; 2012; 40(2):206-19. PubMed ID: 22789041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction: Pharmaceutical firms and the right to health.
    de Campos TC; Pogge T
    J Law Med Ethics; 2012; 40(2):183-7. PubMed ID: 22789038
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical companies and global lack of access to medicines: strengthening accountability under the right to health.
    Grover A; Citro B; Mankad M; Lander F
    J Law Med Ethics; 2012; 40(2):234-50. PubMed ID: 22789043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsibility for global health.
    Buchanan A; DeCamp M
    Theor Med Bioeth; 2006; 27(1):95-114. PubMed ID: 16532305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of international legal instruments to examine their effectiveness in improving global health and in realizing health rights.
    Wilson A; Daar AS
    J Law Med Ethics; 2013; 41(1):89-102. PubMed ID: 23581659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proliferation of human rights in global health governance.
    Gable L
    J Law Med Ethics; 2007; 35(4):534-44, 511. PubMed ID: 18076506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to information and the right to health: the human rights case for clinical trials transparency.
    Lemmens T; Telfer C
    Am J Law Med; 2012; 38(1):63-112. PubMed ID: 22497094
    [No Abstract]   [Full Text] [Related]  

  • 19. Restoring a reputation: invoking the UNESCO Universal Declaration on Bioethics and Human Rights to bear on pharmaceutical pricing.
    Hurst DJ
    Med Health Care Philos; 2017 Mar; 20(1):105-117. PubMed ID: 27796725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combating counterfeit medicines and illicit trade in tobacco products: minefields in global health governance.
    Liberman J
    J Law Med Ethics; 2012; 40(2):326-47. PubMed ID: 22789049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.